Navigation Links
TransMessenger Transfection Reagent Handbook

web site contains siRNA transfection protocols and the most up-to-date information and literature on QIAGEN reagents for RNAi. Visit the Transfection Tools site for answers to your RNAi questions www.qiagen.com/transfectiontools/.

Optimizing siRNA Transfection

To achieve the best results in siRNA transfection we recommend optimizing the following parameters.

Amount of siRNA and Enhancer R
The amount of siRNA used is a critical factor for efficient transfection and gene silencing. The recommended starting amount for transfection of siRNA in 24-well plates is 0.8 g. A pipetting scheme for optimizing the transfection of siRNA in adherent cells in a 24-well format is provided in Table 4 on page 16. Always use a 1:2 ratio of nucleic acid (g) to Enhancer R (l).

Ratio of TransMessenger Transfection Reagent to siRNA
The ratio of TransMessenger Transfection Reagent to siRNA should be optimized for every new cell type and siRNA combination used. As a starting point for optimization we recommend using an siRNA to TransMessenger Transfection Reagent ratio (g:l) of 1:5 when using 24-well plates. To optimize siRNA transfection in 24-well format, prepare separate transfection mixtures using:
The starting point siRNA and TransMessenger Reagent quantities that are given in the protocol on page 16
Half the listed quantities and ratios
Double the listed ratios and quantities.

Cell density at transfection
The optimal confluency for transfection of adherent cells with siRNA is 5080%. The optimal confluency should be determined for every new cell type
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. TransMessenger Transfection Reagent
2. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
3. TransMessenger Transfection Reagent
4. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
5. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
6. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
7. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
8. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
9. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
10. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
11. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: TransMessenger Transfection Reagent Handbook

(Date:5/28/2015)... DUBLIN , May 27, 2015 ... addition of Jain PharmaBiotech,s new report "Cell ... their offering. This report describes and ... already started to play an important role in ... is replacing the old fashioned bone marrow transplants. ...
(Date:5/28/2015)... CARLOS, Calif. , May 28, 2015 /PRNewswire/ ... testing, today announced a study published in ... the Panorama single-nucleotide polymorphism (SNP)-based non-invasive prenatal test ... the first trimester. A study ... that complete molar pregnancies occur in about 1 ...
(Date:5/28/2015)... MARLBOROUGH, Mass. , May 28, 2015 ... company focused on discovering and developing innovative therapeutics, primarily ... the pricing of a public offering of 26 million ... per share for gross proceeds of approximately $10.4 million. ... stock, (ii) a 13-month overallotment purchase right to purchase ...
(Date:5/28/2015)... 28, 2015 The Fertility Centers of ... Dr. Danielle Vitiello has taken on a new and ... Vitiello will provide guidance, leadership, oversight and quality assurance ... Dr. Vitiello among our team of experienced reproductive endocrinologists,” ... Joseph A. Hill, M.D. “Her expertise and compassionate, individualized ...
Breaking Biology Technology:Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2
... October 20, 2011 -- "Working Toward a ... Key Trends in Breast Cancer Research Article Output -- ... scientific community in the publication of breast cancer research articles, ... a Cure: Examining   the State of Global Breast Cancer ...
... DIEGO, Oct. 20, 2011 Verenium Corporation (Nasdaq: ... and commercializing high-performance enzymes, today announced that it has ... Export-Import Bank of the United States ("Ex-Im Bank") for ... $13 million. These new credit facilities ...
... PARIS, October 20, 2011 - New findings from the ... ACTRIMS Congress - - U.S. FDA Accepts New ... - Sanofi (EURONEXT: SAN and NYSE: ... pivotal TE riflunomide M ultiple S clerosis O ...
Cached Biology Technology:United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report 2United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report 3United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report 4United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report 5Verenium Announces Up to $16 Million in New Secured Financings 2Verenium Announces Up to $16 Million in New Secured Financings 3Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 2Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 3Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 4Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 5Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 6
(Date:5/6/2015)... TEL AVIV, Israel , May 6, 2015 /PRNewswire/ ... the world,s most established helmet producer, announced today that ... LifeBEAM Smart Helmet, the world,s first bio-sensing cycling helmet ... will be released in two new colors in order ... demand for the product. In addition, LifeBEAM and Lazer ...
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, Inc. ... and security systems is pleased to announce that Dr ... a consultant and member of its scientific advisory board. ... known as a thought leader in technology-enhanced learning models. ... Group, and has published studies and books focused on ...
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... NY The Feinstein Institute for Medical Research today ... Massachusetts Institute of Technology (MIT) being spearheaded by GlaxoSmithKline ... impulses to regulate the body,s organs and functions. This ... Nature . "This is a powerful collaboration between ...
... of cases, novel drugs tested on humans by pharmaceutical companies do ... drugs do not work, while at worst, test subjects die.,New research ... can be reduced. The secret is to test the drug on ... of 15 liver patients who participated in a medical trial following ...
... at the University of York and the Royal Society for ... have colonised the UK in recent decades breed initially almost ... wildlife., First author, Jonathan Hiley, a PhD student in the ... welcome mats for new arrivals.", Published online in the journal ...
Cached Biology News:Feinstein Institute collaborates with GSK, UPenn, MIT to research body's electrical impulses 2New cutting-edge cell research will lead to safer medical experiments on humans 2New cutting-edge cell research will lead to safer medical experiments on humans 3New cutting-edge cell research will lead to safer medical experiments on humans 4Protected wildlife areas are 'welcome mats' for UK's bird newcomers 2
Proliferin (C-14)...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
... Ascent is a dedicated fluorometer ... all kinds of assays in ... for clinical applications. Cell biology, ... all important application areas. Robot-friendly ...
... SpeedVac Concentrator, the SPD series takes the ... modern twist., The SPD121P SpeedVac comes equipped ... optimizing runs; preventing samples from freezing; and ... the end-users preset level., Standard features on ...
Biology Products: